InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Zorax Free
04/25/25 7:56 PM
profile icon
Wolf-man jack Free
04/23/25 3:33 PM
Bullish
Bullish
profile icon
g247 Free
04/23/25 11:30 AM
profile icon
Wolf-man jack Free
04/22/25 11:15 AM
Bullish
Bullish
profile icon
Wolf-man jack Free
04/22/25 7:37 AM
Bullish
Bullish
profile icon
Blueduke Free
04/21/25 11:45 AM
profile icon
Blueduke Free
04/21/25 10:51 AM
profile icon
Wolf-man jack Free
04/21/25 5:29 AM
Bullish
Bullish
profile icon
Talisman33 Free
04/20/25 6:41 PM
profile icon
Thomas@yahoo Free
04/19/25 10:30 AM
Bullish
Bullish
profile icon
Blueduke Free
04/16/25 3:11 AM
Bearish
Bearish
profile icon
Wolf-man jack Free
04/16/25 1:58 AM
Bullish
Bullish
profile icon
Thomas@yahoo Free
04/15/25 7:17 PM
Bullish
Bullish
profile icon
Blueduke Free
04/15/25 8:21 AM
Bearish
Bearish
profile icon
Wolf-man jack Free
04/14/25 4:06 PM
Bullish
Bullish
profile icon
Blueduke Free
04/14/25 2:38 PM
profile icon
Wolf-man jack Free
04/14/25 1:36 PM
Bullish
Bullish
profile icon
Wolf-man jack Free
04/14/25 10:38 AM
Bullish
Bullish
profile icon
Wolf-man jack Free
04/14/25 9:22 AM
Bullish
Bullish
profile icon
Talisman33 Free
04/13/25 9:58 PM
profile icon
Wolf-man jack Free
04/13/25 8:30 AM
Bullish
Bullish
profile icon
Thomas@yahoo Free
04/10/25 7:37 AM
Bullish
Bullish
profile icon
Wolf-man jack Free
04/08/25 3:56 AM
Bullish
Bullish
profile icon
Thomas@yahoo Free
04/07/25 7:05 PM
Bullish
Bullish
profile icon
Thomas@yahoo Free
04/07/25 7:35 AM
Bullish
Bullish

CV Sciences Inc (CVSI) RSS Feed

Followers
568
Posters
Posts (Today)
0
Posts (Total)
83926
Created
02/27/13
Type
Free
Moderators Zorax Wolf-man jack Thomas@yahoo
 

CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs

CV Sciences (PRNewsfoto/CV Sciences, Inc.)

November 21,2024

https://www.prnewswire.com/news-releases/cv-sciences-inc-enters-into-definitive-agreement-to-acquire-extract-labs-302313574.html

https://www.extractlabs.com/

CV Sciences Acquires Extract Labs
Based on the provided search results, here’s a summary of the information related to Extract Labs and CV Sciences:

Acquisition: CV Sciences, Inc. (OTCQB:CVSI) has entered into a definitive agreement to acquire Extract Labs, Inc., a manufacturer and distributor of premium cannabinoid products, including gummies, topicals, and tinctures. The acquisition is valued at $400,000 in cash and $1,000,000 in CV Sciences’ common stock, with potential additional shares based on revenue targets.

Extract Labs’ Operations: Extract Labs has operational flexibility, allowing for low to large minimum order quantity production runs, enabling efficient use of capital and increased speed to market for new product development. The company is GMP-certified and FDA-registered.

Post-Acquisition Plans: CV Sciences plans to increase Extract Labs’ existing revenue base and further leverage its existing capacity. Additionally, CV Sciences intends to in-source the manufacturing of select +PlusCBD™ branded products, providing an opportunity for meaningful cost savings.

Financial Considerations: The total consideration for the acquisition payable at closing consists of a cash payment of $400,000, less certain holdbacks and adjustments, and the issuance of shares of CV Sciences’ common stock valued at $1,000,000 based on the 60-day volume-weighted average price of CV Sciences’ common stock. Extract Labs sellers will be eligible for up to $600,000 of additional shares if certain revenue targets are met during the two 12-month periods following the closing date.

Business Overview: CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods, with a focus on hemp extracts and other proven, science-backed ingredients and products. The company’s +PlusCBD™ branded products are sold through various channels, including retail locations and online.

Extract Labs’ Products: The company offers a range of products, including gummies, topicals, and tinctures, which are sold through business-to-business (B2B) and business-to-consumer (B2C) channels.

Quality and Testing: CV Sciences has high standards for quality, purity, and potency of its CBD products, with third-party lab testing to ensure the absence of pesticides, fungicides, plant growth regulators, residual solvents, heavy metals, and microbiological contamination.




CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

(PRNewsfoto/CV Sciences, Inc.)

 

CV Sciences, Inc., a consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, acquired Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry, in May 2024.

Key Highlights:

  1. Operational Flexibility: Elevated Softgels offers low to large minimum order quantity (MOQ) production runs, enabling efficient use of capital and rapid product development.
    GMP-Certified and FDA-Registered: The manufacturing facility is certified by Good Manufacturing Practices (GMP) and registered with the US Food and Drug Administration (FDA), ensuring high-quality products.
    Scalability: The acquisition enables CV Sciences to increase production capacity, leveraging Elevated Softgels’ ability to manufacture millions of softgels per day.
    Cost Savings: CV Sciences plans to in-source the manufacturing of select +PlusCBD branded products, resulting in meaningful cost savings.
    Synergies: The acquisition is expected to drive long-term growth and shareholder value by leveraging CV Sciences’ relationships with other hemp and supplement companies.

Product Offerings:

Elevated Softgels manufactures a range of products, including:

  1. CBD Softgel Capsules: Reserve Collection Softgels featuring 25 mg of CBD, terpenes, minor cannabinoids, fatty acids, and 2.5 mg of THC per daily recommended serving.
    Custom Softgels: Clients can create their own custom softgels with various strengths, carrier oils (organic or conventional), and MCT or hemp seed oil options.
    Tinctures: Stock formulas and custom options available, with the ability to change flavors at 100 units and bottle designs at 360 units.

Manufacturing Capabilities:

Elevated Softgels’ large-scale softgel manufacturing setup allows for:

  1. High-Volume Production: Over 100,000 softgels per hour or millions per day.
    Bulk or Bottled Options: Clients can purchase products in bulk or bottled units, with stock components kept in-house for rapid fulfillment.

Conclusion:

The acquisition of Elevated Softgels by CV Sciences enhances the company’s product offerings, manufacturing capabilities, and scalability, positioning it for long-term growth and success in the consumer wellness industry.

 




DECEMBER 12, 2023

https://vegconomist.com/investments-finance/investments-acquisitions/cv-sciences-expands-european-plant-based-food-market-acquisition-cultured-foods/

https://culturedfoods.eu/our-products

https://veggs.eu/
SAN DIEGODec. 12, 2023 /PRNewswire/ -- CV Sciences, Inc.(OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated its purchase of Cultured Foods, a leading manufacturer and distributor of alternative plant-based vegan foods.  Cultured Foods produces a variety of curated plant-based products, currently sold in 15 different European countries, with its base of operations in Warsaw, Poland.  The acquisition creates opportunity for importation of these specialty foods to the US and establishes a European base of operations for the sale and distribution of +PlusCBD products, opening doors to numerous new retail and distributor partners.  In addition, it helps accelerate CV Sciences transition to a more diverse global health and wellness company.  The acquisition was structured as an equity purchase, where the Company will operate Cultured Foods as its wholly-owned subsidiary."


https://finance.yahoo.com/news/cv-sciences-inc-acquires-cultured-130000039.html

CV SCIENCES CORPORATE PRESENTATION 
November 2023


https://d1io3yog0oux5.cloudfront.net/_6345b7c0057da3484b9f63505fa8fd81/cvsciences/db/354/2772/pdf/CVSICorpDeckOct2023_16112708099.pdf

California has come out with a list of authorized industrial hemp firms who are abiding by the state laws thru registering. This process cost money. Many of CVSI competitors are not on the list. Hopefully there would be some enforcement. 
https://www.cdph.ca.gov/Programs/CEH/DFDCS/CDPH%20Document%20Library/FDB/FoodSafetyProgram/IndustrialHemp/AuthorizedIHFirms.pdf

Its been two years in the making but yes AB 45 kicking in should be huge news. 
“As a California-based company, we are very pleased with the enactment of AB 45, which we believe will lead to significant retail expansion of CV Sciences’ PlusCBD™ products in our home state
 
https://ir.cvsciences.com/press-releases/detail/183/cv-sciences-inc-applauds-the-california-legislature-for
 



CV SCIENCES CORPORATE PRESENTATION 
January 2022


https://d1io3yog0oux5.cloudfront.net/_43b427c2b7495b85d93c402f5a0f0693/cvsciences/db/354/2712/pdf/CVSI+IR+Deck+January+2022.pdf

PRESS RELEASES 

https://ir.cvsciences.com/press-releases

CVSI DAILY & WEEKLY CHART 

https://stockcharts.com/h-sc/ui?s=cvsi

SEC FILINGS 

https://www.sec.gov/cgi-bin/browse-edgar?company=Cv+sciences+&owner=exclude&action=getcompany

SHARE STRUCTURE 

https://www.otcmarkets.com/stock/CVSI/security

WISE WQLF NORDIC NATURALS PROBABLE PARTNERSHIP UPDATE  
January 22, 2023


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171004156

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171000947

Stuart Tomc 14 November, 2022 Interview Corinna Bellizzi 
Omega 3 and PLUSCBD Combination 

https://orlonutrition.com/blogs/podcast/what-you-re-missing-out-on-not-consuming-omega-3-and-cbds-with-stuart-tomc

As FDA investigates CBD, recent omega-3 ruling may have impact 
Rick Vach May 13, 2019
 

https://www.chiroeco.com/cbd-products/


CBD, Omega-3 Fatty Acids, and the Endocannabinoid System 
Author: Gina Jaeger, PhD 
Last reviewed on December 04, 2019 


https://www.nordic.com/healthy-science/cbd-omega-3-fatty-acids-and-the-endocannabinoid-system/

SLEUTH SAID;  

 
Japan has granted a second patent to cvsi. January 4th. Just the fact that they continue to prosecute international applications is a good sign. 

https://patentscope.wipo.int/search/en/detail.jsf?docPN=JP2021059575

About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB: CVSI) is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from B2B to B2C. The Company's +PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are one of the top-selling brands of hemp extracts in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences follows all guidelines for Good Manufacturing Practices (GMP) and the Company's products are processed, produced, and tested throughout the manufacturing process to confirm strict compliance with company standards and specifications. With a commitment to science, +PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company also operates a drug development division focused on developing and commercializing CBD-based novel therapeutics. CV Sciences, Inc. has primary offices and facilities in San Diego, California.  Additional information is available from OTCMarkets.com or by visiting


https://www.cvsciences.com/
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post